Teva Buying HGS Spinout CoGenesys for $400M Cash Jan. 23, 2008 By Jennifer Boggs Privately held CoGenesys Inc., a 2006 spinout of Human Genome Sciences Inc., is being acquired by potential collaborator Teva Pharmaceutical Industries Ltd. in a $400 million cash deal. (BioWorld Today)Read More
Deals roundup: Roche ups offer price for Ventana to $89.50 share, about $3 billion Jan. 23, 2008 By Amanda Pedersen
Washington roundup: Specialty hospital group says OIG report ‘blatantly false’ Jan. 22, 2008 By Mark McCarty
RSS